Ot­su­ka pens AAV deal with Shape Ther­a­peu­tics for eye gene ther­a­pies

Last year
Deals
Cell/Gene Tx

Bi­par­ti­san House group calls on FDA to en­sure OTC and pre­scrip­tion ver­sions of a drug can­not be mar­ket­ed ...

Last year
FDA+

Mer­ck to face FDA ad­comm in No­vem­ber over pre­vi­ous­ly re­ject­ed po­ten­tial chron­ic cough drug

Last year
Pharma
FDA+

Bris­tol My­ers Squibb and Cel­gene named in class ac­tion suit over can­cer block­buster Po­m­a­lyst

Last year
Pharma
Law

IPG Health de­buts new clin­i­cal tri­al di­ver­si­ty ap­proach based on ex­pe­ri­ence and spurred by phar­ma re­quests

Last year
Pharma
Marketing

Man­u­fac­tur­ing roundup: Bio­con ac­quires New Jer­sey man­u­fac­tur­ing site for $7M+; Ghana­ian man­u­fac­tur­er to fill-fin­ish ...

Last year
Manufacturing

Phar­ma trade group and pa­tient or­ga­ni­za­tion pres­sure Con­gress with TV ad cam­paigns

Last year
Pharma
Marketing

Vaxart re­ports mixed PhII da­ta for norovirus vac­cine; J&J to pro­ceed with Cidara in­fluen­za deal 

Last year
News Briefing

For­mer Google AI leader lands $100M Se­ries A raise for 'bi­o­log­i­cal soft­ware' start­up

Last year
Financing

El­e­ment Bio­sciences logs 100 DNA se­quencer or­ders as it gains mo­men­tum in a com­pet­i­tive mar­ket

Last year
Diagnostics

Al­ny­lam, Roche’s RNAi can­di­date scores mid-stage win in hy­per­ten­sion

Last year
R&D

Val­ne­va and Pfiz­er tout re­sults for the PhII of its Ly­me dis­ease vac­cine

Last year
R&D

CymaBay meets pri­ma­ry, key sec­ondary end­points in PhI­II liv­er tri­al

Last year
R&D

Seagen teams up with pro­tein degra­da­tion spe­cial­ist to make a new kind of an­ti­body con­ju­gate, pay­ing $60M up­front

Last year
Deals

J&J shut­ters PhI­II tri­al for pul­monary hy­per­ten­sion drug, block­ing its ex­pand­ed use as patent ex­piry looms

Last year
R&D
Pharma

Mar­i­ana On­col­o­gy, a ra­dio­phar­ma start­up found­ed by top-tier VCs, nabs $175M Se­ries B

Last year
Financing

Ex­clu­sive: Two ex-Re­cur­sion lead­ers start Noetik in a bid to fix the bro­ken fun­nel in can­cer drug re­search

Last year
Financing
Startups

Ex­clu­sive: Dana­her’s ven­ture arm backs cell ther­a­py man­u­fac­tur­ing start­up co-found­ed by Carl June

Last year
Startups
Cell/Gene Tx

French biotech Cor­te­ria se­cures $70M to re­vive ex-Sanofi heart drugs 

Last year
Financing

Q&A: Bay­er on­col­o­gy head Chris­tine Roth talks strat­e­gy un­der new CEO

Last year
Pharma

FDA ap­proves first gener­ics for Take­da’s Vy­vanse as AD­HD drug short­ages per­sist

Last year
Pharma
FDA+

iP­SC biotech Shore­line Bio­sciences wins patent in­fringe­ment suit over Fate, White­head In­sti­tute

Last year
Pharma
Cell/Gene Tx

Cell­tri­on to build a $94M+ fa­cil­i­ty in South Ko­rea — re­port

Last year
Pharma
Manufacturing

Court agrees with Ab­b­Vie’s method­ol­o­gy for dam­ages in Take­da case

Last year
Pharma
Law
First page Previous page 284285286287288289290 Next page Last page
A service from the Financial Times